EGR1 and breast cancer: Consistent with our previous studies in TKI-sensitive CML [37], knockdown of Egr-1 resulted in decreased Fyn protein expression (Figure 3A), and much like Fyn [42], Egr-1 protein was increased as patients progressed from CP to BC CML (Figure 3B).